Skip to main content
Elsevier

Covid-19 and Parkinsonism

  • 1st Edition, Volume 165 - September 22, 2022
  • Latest edition
  • Editors: K. Ray Chaudhuri, Mayela Rodriguez-Violante, Angelo Antonini, Iro Boura
  • Language: English

Covid-19 and Parkinsonism, Volume 165 in the International Review in Neurobiology series, highlights new advances in the field with this new volume presenting interesting chap… Read more

Description

Covid-19 and Parkinsonism, Volume 165 in the International Review in Neurobiology series, highlights new advances in the field with this new volume presenting interesting chapters that cover a variety of topics, including Parkinsonism associated with viral infections, Covid-19 and nervous system pathology: bench to bedside, Prevalence of Covid-19 in Parkinson’s Disease: acute settings and hospital, Covid-19 and Parkinson’s Disease: clinical features, long COVID, Smell deficits in Covid-19 and possible links with Parkinson’s Disease, Spotlight on non-motor symptoms and Covid-19, and a Summary of treatment paradigms in Parkinson’s Disease patients and Covid-19.

Additional sections cover Covid-19 and Parkinson’s Disease: nursing care, vaccination, telemedicine services, impact on advanced therapies, Covid-19-induced parkinsonism: Real life phenoconversion cases, Loneliness and impact of lockdown on Parkinson’s Disease patients during the Covid-19 pandemic, Parkinson’s Disease and Covid-19: Impact of ethnicity and palliative care, and more.

Key features

  • Provides the authority and expertise of leading contributors from an international board of authors
  • Presents the latest release in the International Review of Neurobiology series
  • Updated release includes the latest information on COVID-19 and Parkinsonism

Readership

Undergraduates, graduates, academics, and researchers in the field of Parkinson's disease

Table of contents

1. Parkinsonism associated with viral infection
Irina Ivan, Laura Irincu, Ștefania Diaconu, Cristian Falup-Pecurariu

2. Covid-19, nervous system pathology, and Parkinson’s disease: bench to bedside
Aron Emmi, Iro Boura, Vanessa Raeder, Donna Mathew, David Sulzer, James E. Goldman, Valentina Leta

3. Prevalence and outcomes of Covid-19 in Parkinson’s disease: Acute settings and hospital
Conor Fearon, Alfonso Fasano

4. Covid-19 and Parkinson’s disease: acute clinical implications, long-COVID and post-Covid-19 parkinsonism
Valentina Leta, Iro Boura, Daniel J. van Wamelen, Mayela Rodríguez-Violante, Angelo Antonini, K. Ray Chaudhuri

5. Smell deficits in Covid-19 and possible links with Parkinson’s disease
Aron Emmi, Michele Sandre, Andrea Porzionato, Angelo Antonini

6. Spotlight on non-motor symptoms and Covid-19
Silvia Rota, Iro Boura, Yi-Min Wan, Claudia Lazcano-Ocampo, Mayela Rodríguez-Violante, Angelo Antonini, K. Ray Chaudhuri

7. Treatment paradigms in Parkinson’s disease patients and Covid-19
Iro Boura, Lucia Batzu, Espen Dietrichs, K. Ray Chaudhuri

8. Covid-19 and Parkinson’s disease: Nursing care, vaccination and impact on advanced therapies
Anna Roszmann, Aleksandra M. Podlewska, Yue Hui Lau, Iro Boura, Annette Hand

9. Social Isolation, loneliness and mental health sequelae of the Covid-19 pandemic in Parkinson’s disease
Bradley McDaniels, Indu Subramanian

10. Parkinson’s disease and Covid-19: Is there an impact of ethnicity and the need for palliative care
Katarina Rukavina, Victor McConvey, K. Ray Chaudhuri, Janis Miyasaki

11. Covid-19 : The Cynosure of Rise of Parkinson’s Disease
Prashanth Lingappa Kukkle

12. Parkinson’s disease and Covid-19: The Effect and Use of Telemedicine
Aleksandra M. Podlewska, Daniel J. van Wamelen

13. Impact of Covid-19 on research and training in Parkinson’s disease
Yi-Min Wan, Daniel J. van Wamelen, Yue Hui Lau, Silvia Rota, Eng-King Tan

Product details

  • Edition: 1
  • Latest edition
  • Volume: 165
  • Published: October 6, 2022
  • Language: English

About the editors

KC

K. Ray Chaudhuri

Professor K. Ray Chaudhuri is Professor of Neurology/Movement Disorders at King’s College Hospital and King’s College London and Director of the Parkinson Foundation International Centre of Excellence at King’s College. He is Chairman of the Industry Engagement Committee, and Co Chair Task force of the Parkinson Wellness committee of the Movement Disorders Society (MDS and Ex Chair Membership and Public Relations Committee of the Movement Disorders Society (MDS), was a member of the MDS Congress Scientific Programme Committee (2013-2017) and is Founder and Ex Chairman and current steering group member of the MDS Non-Motor Parkinson’s Disease Study Group and a member of the MDS-ES Education committee and Evidence Based Medicine committee (Nonmotor symptoms). He was the founder -Editor-in-Chief of the njp Parkinson’s Disease (2020 impact factor >8), Guest Editor for special editions of Frontiers in Neurology and Journal of Parkinson’s Disease, reviewer for all mainstream movement disorders journals as well as JAMA, Neurology, Annals of Neurology, BMJ, Brain, Lancet, and Journal of Neurology, Neurosurgery, and Psychiatry. He serves as an advisor (MHRA health technology and scientific advisor) to the UK National Institute for Health and Care Excellence, NHS England, General Medical Council as well as Parkinson’s UK and Parkinson’s Europe. Professor Chaudhuri is the author of over 500 articles, co-editor of 5 books on Parkinson’s disease and restless legs syndrome, and winner of the British Medical Association Book Awards commendation in 2015 and 2017. He is also the recipient of 2018 Jay Van Andel Award Outstanding Achievement in Parkinson’s Disease Research (pioneering holistic assessments and non-motor subtypes), as well as National Institute for Health Research/Royal College of Physicians award for outstanding research leadership in 2017. He was elected honorary member of the Movement Disorders Society in 2021, Honorary Professor Brasov University, Honorary Professor SRM University, India and received the UK NHS Gold merit award in 2021 for excellence in research and clinical service. In 2023 he was featured as “role model” in British Medical Journal. He has been a guest lecturer worldwide, including in Japan, China, Taiwan, Vietnam, Thailand, Singapore, Australia, India, Africa, the US, Russia, and Europe. In 2022/2023 he is ranked fourth in the world for Parkinson’s publications/expertise and expertise since 2014 and no 1 in the UK (expertscape: Parkinson’s disease).

Affiliations and expertise
Basic and Clinical Neuroscience department, Institute, Institute of Psychiatry, Psychology and Neuroscience, and Parkinson’s Foundation Centre of Excellence, King’s College Hospital, Kings College, London, UK

MR

Mayela Rodriguez-Violante

Attending neurologist at the National Institute of Neurology and Neurosurgery in Mexico City. Responsible of the Clinical Neurodegenerative Research Unit. Movement disorders training at the Hospital Clinic de Barcelona. Master in Sciences granted by the UNAM. Member of the National Research System (SNI level 3). Member of the National Academy of Medicine. Principal Professor of the Parkinson’s disease and Movement Disorders high specialty course recognized by the Health’s Ministry and the UNAM
Affiliations and expertise
National Institute of Neurology and Neurosurgery, Mexico City, Mexico

AA

Angelo Antonini

Angelo Antonini graduated in Medicine in 1986 and completed Neurology training in 1990 at the University of Rome “La Sapienza” in Rome where he developed skills in neuropharmacology and movement disorders. After obtaining a scholarship in 1990, in 1991 he started a PhD in Neuroradiology with PET and MRI at the University of Zurich and the Institute of Physics Paul Scherrer in Villigen, Switzerland, which he completed in 1994. PET studies focused on the dopaminergic system, metabolic disorders and cerebral blood flow in healthy subjects, in Parkinson patients and with other movement disorders as well as psychiatric disorders. MRI studies focused on the study of signal T2 and its relationship with free iron as degeneration biomarkers. After one year as Post- Doc in Zurich, in October 1995 he continued his research at the Neuroimaging Laboratory of NY Shore University Hospital and was promoted to Assistant Professor at New University York. During this period, the research focused on the study of brain networks and their modulation with pharmacological and surgical interventions. In November 1997, he returned to Italy in Milan at the Parkinson Institute where he contributed to the development of a research centre for Parkinson’s disease and implemented clinical trials and functional surgery at the Department of Neuroscience in collaboration with the University of Milan -Bicocca. In 2010 he moved to Venice in the National Research Institute San Camillo where he is responsible of the Unit for Parkinson and Movement Disorders and became Associate Professor of Neurology at the University of Padua. During his career, he received several academic awards and funding (including an ongoing Horizon2020 project), published over 340 peer reviewed manuscripts, has a H-Index (Scopus) of 62 and over 13000 citations. He has been an invited speaker at national and international neurology congresses in over 40 countries around the world. He has organized international courses and conferences. He is an honorary member of the Society of Neurology of France and of Romania. It serves as a reviewer for the main neurological journals. He is a Fellow of the European Academy of Neurology, President Elect of the European Section of the Movement Disorders Society and Auditor of the Italian Parkinson’s and Movement Disorders Academy.
Affiliations and expertise
Professor of Neurology, University of Padua, Italy

IB

Iro Boura

Iro Boura, MD, MSc is a PhD student at the University of Crete in Heraklion, Greece, investigating the neurogenetics and phenomenology of Parkinson’s Disease on the island of Crete, and is currently employed as a Neurology Consultant in the General Hospital of Chania in Crete, Greece. Prior to this position, she worked as a clinical research fellow in the Institute of Psychiatry, Psychology & Neuroscience, King’s College London, UK and at King’s College Hospital NHS Foundation Trust in London, UK under the supervision of Prof K. Ray Chaudhuri. She is currently continuing their collaboration as an affiliated member at King’s College London and the Parkinson’s Foundation Centre of Excellence in King’s College Hospital, UK. Dr. Boura received her MSc in Mental Health and Neuropsychiatry from the National and Kapodistrian University of Athens, Greece. During the past few years she has been involved in numerous publications and presentations relevant to Parkinson’s Disease.
Affiliations and expertise
International Centre of Excellence in Parkinson’s and Movement Disorders, King's College London, UK

View book on ScienceDirect

Read Covid-19 and Parkinsonism on ScienceDirect